Nephros, Inc.
NEPH
$1.63
$0.00990.61%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 49.48% | 21.91% | 40.75% | 62.06% | 57.59% |
| Total Depreciation and Amortization | -29.82% | 8.64% | -8.92% | -14.74% | -23.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.94% | 8.29% | 4.49% | 39.28% | -26.51% |
| Change in Net Operating Assets | -246.26% | -171.73% | -65.61% | 697.12% | 361.94% |
| Cash from Operations | -333.95% | -376.22% | 87.79% | 126.99% | 127.12% |
| Capital Expenditure | -- | -- | 27.18% | 45.26% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 27.18% | 45.26% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 95.51% | 95.51% | 96.83% | 63.59% | 22.77% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 96.26% | 96.26% | 97.22% | -176.70% | -205.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -417.45% | -916.67% | 84.92% | 121.71% | 121.51% |
